Clinical trial
Efficacy and Safety Study of GerEPO
NCT00229099 · Ministry of Health, Malaysia, Other · Completed
Key facts
| NCT number | NCT00229099 |
|---|---|
| Title | Efficacy and Safety Study of GerEPO |
| Official title | A Randomized, Multi-Center, Open Label Trial to Establish the Therapeutic Equivalence Between GerEpo and Eprex® and to Determine the Long Term Safety Profile of GerEpo in Patients on Hemodialysis. |
| Lead sponsor | Ministry of Health, Malaysia, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Chronic Renal Failure Related Anemia |
| Intervention type | Drug |
| Interventions | GerEPO |
| Enrollment | 270 |
| Start date | Apr 1, 2005 |
| Completion | Nov 1, 2005 |
| First posted | Sep 29, 2005 |
| Last update posted | Oct 26, 2006 |
| Countries | Malaysia |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: